AP NEWS

The Global Market for Testosterone Replacement Therapy (2019-2023): Leading Players are AbbVie, Bayer and Endo Pharmaceuticals - ResearchAndMarkets.com

January 10, 2019

DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “Global Testosterone Replacement Therapy Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The testosterone replacement therapy market growth at a CAGR of more than (2%) during the forecast period.

The latest trend gaining momentum in the market is due to availability of such patient assistance programs, individuals are inclined toward buying these drugs, thereby increasing the growth of the market.

According to the report, one of the major drivers for this market is the increasing awareness about hypogonadism among the public and primary care physicians will drive the market.

Further, the report states that one of the major factors hindering the growth of this market is the availability of generics in the market acts as a challenge of the growth of the market.

Key Players

AbbVie Bayer Endo Pharmaceuticals

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product Comparison by product Injections - Market size and forecast 2018-2023 Topicals - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors AbbVie Bayer Endo Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/34dm3s/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005316/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/10/2019 06:56 AM/DISC: 01/10/2019 06:56 AM

http://www.businesswire.com/news/home/20190110005316/en

AP RADIO
Update hourly